Nobel Prizewinner David Baltimore, Ph.D. has always dreamed of turning Los Angeles into a biotech hub. He tried to help it along as president of the California Institute of Technology some 20 years ago, but the idea didn’t seem to stick. Now, he’s getting another crack at it with a new cancer cell therapy company co-founded with a group of Caltech and Kite Pharma alums.
Other articles
June 28, 2024
Freeflow Ventures Raises $90M In Funding For Early Stage Deep Tech Investments
Freeflow Ventures, announced today that it raised $50M in new funds through its…